What will Johnson & Johnson say during their next earnings call?

As of Tue, 20 Oct 2026 11:11:55 UTC, Kalshi traders price Rybrevant (89.0%), Firefly Bio (87.0%), Procedure (87.0%). The market has $2K in volume and closes on Tue, 26 Jan 2027.

Updated:

Current odds

OutcomeChanceYes priceNo price
Rybrevant89.0%89.0¢11.0¢
Firefly Bio87.0%87.0¢13.0¢
Procedure87.0%87.0¢13.0¢
China86.0%86.0¢14.0¢
Tecvayli85.0%85.0¢15.0¢
Caplyta85.0%85.0¢15.0¢
Ottava83.0%83.0¢17.0¢
Tariff79.0%79.0¢21.0¢
Litigation70.0%70.0¢30.0¢
Darzalex Faspro69.0%69.0¢31.0¢
Sail Biomedicines63.0%63.0¢37.0¢
AI / Artificial Intelligence34.0%34.0¢66.0¢
Halda Therapeutics24.0%24.0¢76.0¢
Nipocalimab / Lupus21.0%21.0¢79.0¢
Vaccine7.0%7.0¢93.0¢

Market details

Resolution rules

Each outcome is a separate contract with its own rules. The rules for Rybrevant:

If Rybrevant is said by any Johnson & Johnson representative (including the operator of the call) during the next Johnson & Johnson live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. How this is resolved Video of the Johnson & Johnson earnings call. If a consensus by Kalshi employees cannot be reached using video, transcripts of the Johnson & Johnson earnings call will be used according to the news publications listed in the contract. Payout criteria The exact phrase/word, or a plural or possessive form of the phrase/word. Doesn't count for payout Grammatical/tense inflections. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.

Sources

Related markets

DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.